Insider · CIK 0001673277
Francis Richard D
directorceopresidentofficer
Files at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD), MTD (METTLER TOLEDO INTERNATIONAL INC/). First filing Feb 19, 2025, latest Mar 6, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $2.2M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 21Weak | sell 510b5-1 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | $376k | 23,773 | -8% | - | |
| 28Weak | sell 510b5-1 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | $503k | 31,342 | -11% | - | |
| 40Moderate | sell 510b5-1 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | $1.3M | 75,506 | -26% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | AGrant or award Restricted Share Unitsderivative | +169,811 | $0.00 | $0 | 169,811 | Mar 7, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +50,223 | - | - | 295,556 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -15,514 | $15.73 | $244k | 280,042 | Mar 6, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -8,259 | $15.91 | $131k | 271,783 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -50,223 | $0.00 | $0 | 150,669 | Mar 6, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +67,231 | - | - | 276,675 | Mar 5, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -24,892 | $16.19 | $403k | 251,783 | Mar 5, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -6,450 | $15.56 | $100k | 245,333 | Mar 5, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -67,231 | $0.00 | $0 | 134,462 | Mar 5, 2025 |
| Feb 15, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +161,655 | - | - | 284,950 | Feb 19, 2025 |
| Feb 18, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -75,506 | $16.95 | $1.3M | 209,444 | Feb 19, 2025 |
| Feb 15, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -161,655 | $0.00 | $0 | 161,656 | Feb 19, 2025 |
| Nov 12, 2024 | MTD METTLER TOLEDO INTERNATIONAL INC/ | AGrant or award Common Stock, par value $0.01 per share | +71 | $0.00 | $0 | 624 | Nov 14, 2024 |
| Nov 12, 2024 | MTD METTLER TOLEDO INTERNATIONAL INC/ | AGrant or award Stock Option (right to buy)derivative | +182 | $0.00 | $0 | 182 | Nov 14, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.